
‘Subnautica 2' leaders say Krafton sabotaged game over payout
Former Unknown Worlds chief executive officer Ted Gill and founders Charlie Cleveland and Max McGuire said Krafton sought to delay the release of their new game, Subnautica 2, after realising they would have to pay that large a sum, according to their complaint. The South Korean game publisher offered the executives a lower payout before terminating their employment earlier this month, the lawsuit alleges.
Gill, Cleveland and McGuire filed a lawsuit for breach of contract on July 10. A representative for Krafton declined to comment on the suit. In a statement to press last week, Krafton said the three studio leaders had "abandoned the responsibilities entrusted to them' and that "the absence of core leadership has resulted in repeated confusion in direction and significant delays in the overall project schedule'.
Krafton purchased Unknown Worlds in 2021 for US$500mil (RM2.12bil), with as much as US$250mil (RM1.06bil) more due to be paid in 2026 if the company hit certain revenue targets. The complaint argues that all was well between the two sides until a series of meetings in early 2025 when Gill was negotiating with Krafton about paying bonuses to employees who weren't eligible under the original acquisition terms. About 40 people employed by Unknown Worlds at the time of the sale were told they would receive payouts, mostly in the six-or-seven-figures, but the executives also wanted to offer bonuses to those who had joined later.
During those meetings, Gill said that their revenue projections for the coming year had been conservative and that with the upcoming releases of the original Subnautica on mobile and Switch 2, they were expecting significantly higher numbers. Subnautica 2 was also expected to be a big hit, with nearly 2.5 million people adding the game to their wishlists on the PC platform Steam.
"After Krafton's leaders reviewed Gill's projections and evaluated the anticipated revenue and earnout numbers, everything changed,' they said in their complaint.
The leadership group said that in subsequent meetings, Krafton began pushing for Unknown Worlds to delay Subnautica 2. In the weeks that followed, Krafton employees told Gill they believed the company was trying to get out of paying the earnout, the complaint alleges.
During one lunch meeting, according to the complaint, Krafton chief executive officer Changhan Kim told Cleveland that releasing the game in 2025 "could be disastrous financially and hugely embarrassing' for the company. Krafton later said that had been a mistranslation.
Throughout May and June, the two sides continued to battle as Krafton halted publishing duties such as marketing and adapting the game for local markets, as well as paying vendors, according to the complaint. The former leadership team said that the publisher refused to support the game's imminent summer release and that Unknown Worlds missed out on "highly valuable' promotional opportunities because Krafton didn't respond to emails. Gill said he was told by one of Krafton's top executives that "pulling these resources was a permissible way for Krafton to avoid supporting the earnout', according to the complaint.
By the end of June, the relationship had deteriorated. During various meetings, Krafton asked the leadership group to accept a lower earnout, according to the complaint. Around the same time, Kim wrote a letter to the leaders, reviewed by Bloomberg, accusing them of "failing to fulfill the responsibilities with which you were entrusted' and saying that Subnautica 2 had faced "slow and underwhelming progress'.
On July 1, Krafton fired the three studio leaders, who are now seeking damages "in an amount to be determined at trial', according to their suit. Krafton has said it will extend the bonus period until next year, with Unknown Worlds employees able to share in a US$25mil (RM106.13mil) payout if revenue targets are hit.
One main point of contention between the founders and Krafton was whether the game was ready for release this year under the company's early access model, which allows outsiders to play the game and submit feedback. Presentation slides from Krafton reviewed by Bloomberg, which included quotes from the company's internal testers, argued that Subnautica 2 lacked content and didn't feel innovative enough.
The lawsuit alleges otherwise. Pre-release tests involving hundreds of users "drew high marks and confirmed that the game was ready to meet those lofty expectations", it said.
Developers at Unknown Worlds speaking to Bloomberg said they believed the game was in good shape, as did some external parties, who asked to not be identified. One developer at a separate company who played Subnautica 2 and requested anonymity because they signed a non-disclosure agreement told Bloomberg they enjoyed the game and that it "seemed way more robust' than other titles in early access.
The other point of contention was the roles that Cleveland and McGuire played at the studio. In public statements and in documentation reviewed by Bloomberg, Krafton accused the two founders of neglecting their duties because they were minimally involved with the development of Subnautica 2.
In their suit, the founders said that Krafton was aware of their new roles and that Cleveland had spent a large amount of time working on a Subnautica film, which Krafton had asked the studio to develop. – Bloomberg
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


Malaysian Reserve
36 minutes ago
- Malaysian Reserve
Preservative-Free Eye Drops Market Size to reach US$1.67 billion in 2031
NEW YORK, July 18, 2025 /PRNewswire/ — According to a new comprehensive report from The Insight Partners, the global preservative-free eye drops market is growing significantly with the increasing prevalence of ocular diseases. The global preservative-free eye drops market is expected to reach US$1.67 billion in 2031 from US$1.21 billion in 2024. The market is estimated to grow at a CAGR of 4.3% from 2025 to 2031. The increasing prevalence of ocular diseases, the aging global population, surging awareness for chemical-free products, and supportive regulations and recommendations fuel market growth. However, limited availability of such products in the market and shorter shelf life hinder market growth. To explore the valuable insights in the Preservative Free Eye Drops Market report, you can easily download a sample PDF of the report – The preservative-free eye drops market is segmented on the basis of type, application, and distribution channel. The report runs an in-depth analysis of market trends, key players, and future opportunities. Overview of Report Findings Increasing Prevalence of Ocular Diseases: Age-related complications such as cataracts, glaucoma, and macular degeneration are among the top causes of vision loss globally. As per the report 'Age-Related Macular Degeneration: Epidemiology, Pathophysiology, Diagnosis, and Treatment' published in 2022, age-related macular degeneration impacts over 200 million people worldwide and is expected to reach 300 million by 2040. As per the WHO 2023, in Europe, approximately 90 million people have some form of vision impairment or blindness, representing ~9% of the population. The prevalence of these complications highlights the need for efficient eye care treatment. Preservative-free eye drops provide a safer option for people suffering from chronic eye diseases, reducing the risk of preservative-related irritation and toxicity. Rising Aging Population: With age, individuals become more prone to dry eye syndrome, glaucoma, age-related macular degeneration, and cataracts. These disorders need to be treated long-term or even for a lifetime through ophthalmic solutions. But conventional preservative-containing eye drops such as those containing benzalkonium chloride (BAK), are known to induce or worsen irritation, inflammation, and injury to the ocular surface, particularly with prolonged use. Elderly patients are susceptible to such side effects because of thinner tear films and lower regenerative capacity of the ocular surface. Preservative-free eye drops, which provide a milder and safer option, are increasingly being favored among this population. The tendency is particularly prominent in industrialized nations with an accelerating aging population, including Japan, Germany, and the US. It is also gaining prominence in China and India. Clinicians today are inclined to prescribe preservative-free drugs for older patients with chronic diseases. With the world population aged 60 and above expected to double by the year 2050, demand for safer, better-tolerated ophthalmic products will surge, driving market growth. For Detailed Preservative Free Eye Drops Market Insights, Visit: Geographical Insights: In 2024, North America led the market with a substantial revenue share, followed by Europe and Asia Pacific. Asia Pacific is expected to register the highest CAGR in the preservative free eye drops market during the forecast period. Market Segmentation By type, the preservative free eye drops market is segmented into single dose and multiple dose. The single-dose segment held a larger share of the market in 2024, and it is anticipated to register the highest CAGR in the market during 2025–2031. Based on application, the preservative free eye drops market has been segmented into dry eye disease (DED), eye allergy/ infection, glaucoma, retinal disorders, and other indications. The dry eye disease segment held the largest share of the market in 2024 and is expected to register a higher CAGR in the market during 2025–2031. In terms of distribution channel, the preservative free eye drops market is segmented into hospital pharmacies, drug stores and retail pharmacies, and online pharmacies. The hospital pharmacies segment held the largest share of the market in 2024. The online pharmacies segment is expected to register the highest CAGR in the market during 2025–2031. The preservative free eye drops market is segmented into five major regions: North America, Europe, Asia Pacific, Middle East and Africa, and South and Central America. Stay Updated on The Latest Preservative Free Eye Drops Market Trends: Competitive Strategy and Development Key Players: Major companies operating in the preservative free eye drops market are Nemera, Alcon Inc., Bausch & Lomb Incorporated, Eyekare Kilitch Ltd., Essex Bio-Technology Limited, Pillar5 Pharma Inc., iVIZIA, Allergan PLC, CorneaCare Inc. Trending Topics: Dry Eye Disease (DED) Treatment, Glaucoma Therapeutics, Allergic Conjunctivitis Treatment, Contact Lens Care Products, Ophthalmic Surgical Products, Natural and Organic Eye Care Products, Pediatric Eye Care, etc. Global Headlines on Preservative Free Eye Drops Market Lumify Preservative Free Redness-Reducing Eye Drops Launch in US Alcon Announces US Launch of New SYSTANE PRO Preservative-Free, Revolutionizing Dry Eye Relief With Its Long-Lasting Formula Purchase Premium Copy of Global Preservative Free Eye Drops Market Size and Growth Report (2021-2031) at: Conclusion The preservative free eye drops market is growing, driven primarily by the rising prevalence of chronic ocular diseases, an aging global population, and increasing consumer awareness of the adverse effects associated with preservatives. Advances in sterile packaging technologies have made preservative-free formulations more accessible and convenient. Additionally, soaring demand for safer, natural, and more tolerable eye care products aligns with broader healthcare and lifestyle trends. However, higher production costs and limited availability in certain regions limit growth. Overall, the market's future looks promising as healthcare providers and consumers prioritize ocular safety and comfort, making preservative-free eye drops a vital segment in the evolving ophthalmic therapeutics landscape. The report from The Insight Partners lists several stakeholders—including manufacturers, healthcare providers, distributors and suppliers, and regulatory bodies—along with valuable insights on how to successfully navigate this evolving market landscape and unlock new opportunities. Trending Related Reports: The Allergy Relieving Eye Drops Market Size is expected to register a CAGR of 4.2% from 2025 to 2031 Eye Drops and Lubricants Market Size, Trends, Shares, and Forecast – 2031 Dry Eye Disease Market Size is expected to register a CAGR of 5.6% from 2025 to 2031 Diabetic Eye Disease Equipment Market Size, Trends, Shares, and Forecast – 2031 Dry Eye Disease Diagnostic Devices Market Size, Trends, Shares, and Forecast – 2031 The eye allergy treatment market size is projected to reach US$ 5.69 billion by 2030 Retinal Surgery Devices Market Size is expected to register a CAGR of 5.9% from 2025 to 2031 Retinal Implant Market Size is expected to register a CAGR of 8.4% from 2025 to 2031 The Thyroid Eye Disease Treatment Market Size is expected to register a CAGR of 6.3% from 2025 to 2031 About Us: The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We specialize in industries such as Semiconductor and Electronics, Aerospace and Defense, Automotive and Transportation, Biotechnology, Healthcare IT, Manufacturing and Construction, Medical Device, Technology, Media and Telecommunications, Chemicals and Materials. Contact Us:If you have any queries about this report or if you would like further information, please contact us:Contact Person: Ankit MathurE-mail: +1-646-491-9876Press Release – More Life Sciences Research Reports & Industry Analysis – Logo: View original content:


The Star
3 hours ago
- The Star
Weekend for the arts: 'Persiapan Seorang Aktor' theatre, Jemimah Wei KL tour
THEATRE: 'PERSIAPAN SEORANG AKTOR' Venue: Nero Event Space, PJPAC, 1 Utama Shopping Mall Date: ends July 20 Fresh off winning two Boh Cameronian Arts Awards earlier this year - including Best Original Script (for Saat Omar) - Persiapan Seorang Aktor returns this weekend in a new staging by Mask Team and director Syahrul Musa. The Bahasa Malaysia production takes the stage at Nero, PJPac. The 90-minute production features Aloy Paradoks and Fazleena Hishamuddin, joined by acclaimed actor-director Nam Ron for this new run. The play tells the story of a gifted actor whose obsession with greatness slowly eats him alive. Determined to become not just Malaysia's best but the greatest the world has ever seen, he dives into acting with almost religious fervour - quoting theory, living the method, and eventually slipping into isolation, burnout, and depression. At the heart of this unraveling is Nina, his wife, whose quiet devotion brings brief moments of warmth and clarity. Persiapan is both a love letter to the art of acting and a cautionary tale about ego, ambition, and the hidden cost of chasing perfection. Threaded with nods to Hamlet and moving between tragedy and dry humour, the play offers a raw, compelling look at an artist on the edge - and a reminder that even noble dreams can take their toll. Audiences have responded warmly, but if you're hoping to see it, better act fast - only a few nights remain. More info here. THEATRE: 'US A JOURNEY OF LOVE, LOSS & BELONGING' Venue: Pentas 2, KLPac Date: ends July 20 When the lights dim in Us: A Journey Of Love, Loss & Belonging, two characters step onto a bare stage. There's no physical intimacy, no grand gestures, no swelling music – just raw, deliberate dialogue as they try to understand each other and themselves. Written and directed by Fa Abdul, Us is playing at Pentas 2, KLPac in Kuala Lumpur this weekend (July 19 and 20). The play, which made its debut in Penang last month, doesn't promise fairytale endings. Instead, it offers something far more rare: honesty. Starring actors Karam Tabba (a Syrian-born performer) and Lauren Tan (a lawyer, writer, tutor), the play follows Mark and Anna – two emotionally guarded souls bound by deep connection and deeper fear. Ivan Gabriel, a Penang-based artist, actor, and curator, makes a special appearance. As Mark and Anna navigate the tension between closeness and self-preservation, they must confront the emotional walls they've built - can love bridge the gap, or will fear pull them apart? Us is presented by Big Nose Productions and KLPac. More info here. JEMIMAH WEI KL BOOK TOUR Venue: various KL bookstores Date: July 19 and 20 Don't miss out on the chance to meet US-based Singaporean author Jemimah Wei as she visits several bookstores across Kuala Lumpur this weekend: Books Kinokuniya KLCC (July 19), Tsutaya Books Pavilion Bukit Jalil (July 19) and MPH Bookstores The Exchange TRX (July 20). After book tours in the US, Britain and Singapore, Wei is now bringing her newly released debut novel The Original Daughter to Malaysian readers. The book - a project that took the 33-year-old writer over a decade to complete and publish - traces the making and unravelling of family ties against the backdrop of turn-of-the-millennium Singapore. From hiding childhood secrets in biscuit tins to grappling with millennial coming-of-age anxieties, join Wei as she dives into her debut novel and answers questions from readers. More info here. Traditional stage costumes on display at the Chinese Opera exhibition at Muzium Negara, Kuala Lumpur. Photo: The Star/Art Chen CHINESE OPERA EXHIBITION: AN INTRODUCTION AND A REMEMBRANCE Venue: Galeri 1, Muzium Negara, Kuala Lumpur Date: ends Sept 8 The newly opened Chinese Opera Exhibition: An Introduction And A Remembrance at Muzium Negara in Kuala Lumpur takes visitors into the vivid world of traditional Chinese opera – with its legendary tales, striking costumes, delicate props, and timeless music. This showcase is a collaboration between Muzium Negara and the Pat Woh Association Malaysia, a KL-based group known for preserving and promoting Cantonese opera. It also how Malaysian Chinese opera draws from the Xiqu tradition, blending stylised acting, singing, graceful movement, and symbolic props. Visitors can also learn about Malaysia's own opera legends – Siew Chan Wan (1919–2022) and Choo Sau Ying (1927–2003) – whose dedication kept the art form alive for future generations. Choy Him Heong, now 92, continues to be a living link to this enduring tradition. From ornate headgear to hand-painted backdrops, intricate musical instruments to archival photographs, each display – there are more than 90 exhibits – reminds us how Chinese opera has long served as both entertainment and living heritage for generations of local communities. More info here. Visitors view Pangrok Sulap's 'Cahaya Adalah Kehidupan' (2022), a woodcut on blackout fabric, at the Sabahan collective's 'The Sound Of Salience' exhibition at Tali Art Gallery, Petaling Jaya. Photo: The Star/Chan Tak Kong EXHIBITION: PANGROK SULAP's 'THE SOUND OF SALIENCE' Venue: Tali Art Gallery, Petaling Jaya Date: ends July 20 It's the last weekend to catch the exhibition at Tali Art Gallery, showcasing Sabahan collective Pangrok Sulap's bold woodcut works - from pieces dating back to 2017 to a newer series developed in Hong Kong. Titled The Sound Of Salience , the exhibition presents eight main works and assorted prints that showcase Pangrok Sulap's signature fusion of social commentary and participatory printmaking. Renowned for using art as a vehicle for social commentary, the collective's works serve as a bridge between communities and pressing issues like climate change, land rights, cultural identity, and sovereignty. It's been increasingly difficult to catch the group's work in the Klang Valley, as Pangrok Sulap has been actively involved in residencies and exhibitions abroad - most recently with a strong showing at the University of Tennessee in the United States in March, and a community art festival in Patani, southern Thailand last month. Formed in 2010, Pangrok Sulap is made up of artists, musicians, printmakers, and activists. Free admission exhibition. More info here. Lyne Ismail at her painterly debut exhibition 'Cat Town: Energy, Matter, And The Art Of Becoming' at Temu House, Petaling Jaya. Photo: The Star/Azman Ghani EXHIBITION: LYNE ISMAIL'S 'CAT TOWN: ENERGY, MATTER, AND THE ART OF BECOMING' Venue: Temu House, Petaling Jaya Date: ends July 27 Cat Town: Energy, Matter And The Art Of Becoming brings science and art into thoughtful, immersive dialogue. Visual artist, material scientist, and academic Lyne Ismail invites viewers to explore abstraction, sensory perception, and expansive ideas through the lens of resonance and transformation. On view is a new series of large abstract paintings alongside a live cymatic installation, where water responds to sound and vibration by forming intricate, mandala-like patterns. By making resonance visible, Lyne encourages viewers to feel their way into meaning, rather than decode it intellectually. The exhibition also expands on her book Musings Of The Spring Water, launching in tandem with the show. Together, they offer a sensory and reflective journey into energy, intuition, and the act of becoming. More info here.


Free Malaysia Today
3 hours ago
- Free Malaysia Today
Wall Street futures edge up as optimism over economy offsets Netflix's fall
The S&P 500 and the Dow are on track for only modest advances this week, as investors navigate a swirl of mixed signals. (AP pic) NEW YORK : US stock index futures inched higher today, buoyed by signs of a resilient US economy, even as Netflix's market-beating quarterly profit failed to dazzle investors. At 5.30am, S&P 500 E-minis were up 8.75 points, or 0.14%, Nasdaq 100 E-minis were up 33 points, or 0.14%, and Dow E-minis were up 66 points, or 0.15%. Wall Street's winning streak continued overnight, with the S&P 500 and the Nasdaq notching fresh record closes after upbeat data on retail sales and jobless claims signaled a healthy US economy. The data gives the Federal Reserve (Fed) some breathing room to assess the inflationary effects of US tariffs. Netflix rode the success of 'Squid Game' to top earnings estimates and boost its revenue outlook for the year. Yet, the streaming giant's shares slipped 1.5% in premarket trading. It has risen 43% this year. All eyes remain on whether President Donald Trump's tariff measures are starting to ripple through the economy. The Fed has signaled it will stay the course on interest rates until it sees clearer signs of how higher import taxes are shaping inflation. Traders now put the odds of a rate cut in September at about 56.3%, with a July move nearly off the table, according to CME's FedWatch tool. 'This week's data supports the wait-and-see camp on the Fed. 'Tariffs are percolating to consumer prices but is not withholding households from opening their wallets,' said Kenneth Broux, head of corporate research and rates, at Societe Generale. Fed governor Christopher Waller signaled yesterday that mounting economic risks and tame inflation have him backing an interest rate cut by this month's end, downplaying concerns that tariffs will fuel lasting price hikes. As the second-quarter earnings season gets underway, early results from 36 S&P 500 companies that reported, more than 80% have topped Wall Street's earnings expectations, according to LSEG I/B/E/S data. The S&P 500 and the Dow are on track for only modest advances this week, as investors navigate a swirl of mixed signals – robust retail sales, a spike in consumer inflation, and a stall in producer prices for June. Cryptocurrency stocks rose after the US House of Representatives passed a bill that would develop a regulatory framework for cryptocurrencies. Robinhood Markets and Coinbase Global gained 1.9% each, while Bitfarms rose 2.8% and Hut 8 advanced 1.3%.